Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study

To investigate whether atherogenic dyslipidemia, a dyslipidemic profile combining elevated triglycerides and low high-density lipoprotein (HDL) cholesterol, is predictive of risk of silent myocardial ischemia (SMI) or angiographic coronary artery disease (CAD) in asymptomatic patients with type 2 diabetes.

Mots clés

HDL-cholesterol Diabetes Atherogenic dyslipidemia Silent myocardial ischemia Triglycerides Residual cardiovascular risk

Domaines

Sciences du Vivant [q-bio]

Fichier principal

2016 Valensi et al., Atherogenic dyslipidemia.pdf (27.54 Mo)

Origine : Fichiers produits par l'(les) auteur(s)

Dominique MORNET : Connectez-vous pour contacter le contributeur

https://hal.umontpellier.fr/hal-01818507

Soumis le : dimanche 29 mars 2020-11:11:23

Dernière modification le : jeudi 14 décembre 2023-13:50:37

Dates et versions

hal-01818507 , version 1 (29-03-2020)

Licence

Paternité

Identifiants

HAL Id : hal-01818507 , version 1
DOI : 10.1186/s12933-016-0415-4
PRODINRA : 372675
PUBMED : 27450534
WOS : 000381193200001

Citer

Paul Valensi, Antoine Avignon, Ariane Sultan, Bernard Chanu, Minh Tuan Nguyen, et al.. Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study. Cardiovascular Diabetology, 2016, 15 (1), pp.104. ⟨10.1186/s12933-016-0415-4⟩. ⟨hal-01818507⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

INSERM UNIV-PARIS7 UNIV-PARIS13 CNRS INRA USPC BS UNIV-MONTPELLIER INRAE SORBONNE-PARIS-NORD UP-SANTE CRESS

75 Consultations

37 Téléchargements